Rutgers, The State University of New Jersey
502
97
119
226
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
18.7%
94 terminated/withdrawn out of 502 trials
70.6%
-15.9% vs industry average
8%
42 trials in Phase 3/4
58%
131 of 226 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (502)
Acquired Dyslexia Modeling and Treatment
Role: lead
Aim 3, Adapting and Implementing Evidence-based Breast Cancer Follow-up in Primary Care
Role: lead
SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma
Role: lead
Correcting Disinformation About Menthol Cigarettes and Flavored Cigars
Role: lead
Enhancing Screening Practices for BE
Role: lead
Novel Prevention Intervention Program to Reduce Risky Patterns of Substance Use Among Emerging Adults
Role: lead
Skills Video Intervention for Chinese/Chinese Americans
Role: lead
Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer
Role: lead
Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)
Role: lead
Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors
Role: lead
Adapting BA for Minimally Verbal Autistic Adults
Role: lead
History of Neonatology
Role: lead
Clean Beauty in Newark, NJ
Role: lead
ATATcH Alternating Treatment Plans for Advanced Cancer
Role: lead
Diabetes Electronic Prompt for Improved Care Coordination and Treatment in the ED
Role: lead
Virtual Diabetes Care for Adults With Type 2 Diabetes on Medicaid and Insulin Therapy
Role: lead
Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)
Role: lead
Microbiome Derived Metabolism and Pharmacokinetics
Role: lead
Basic and Applied Research on Extinction Bursts
Role: lead
Efficacy and Safety of Intraosseous Antibiotic Prophylaxis in Total Hip Replacement
Role: lead